A study examines quality of life and depression after CAR-T for hematological malignancies

Published Date: 12 Apr 2023

In adults with hematological malignancies receiving chimeric antigen T-cell receptor (CAR-T) therapy, quality of life (QoL) deteriorates, and physical and psychological symptoms worsen one week after infusion and then improve...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot